1.
|
Phase: Phase III, Phase II Type: Behavioral study, Biomarker/Laboratory analysis, Supportive care Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: BRS0008, K07CA132916-01A1, 25740, NCT01011218
|
|
2.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: CA151445, R01CA151445, NCT01281904
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: UCCO08106; URCC0701, U10CA037420, UCCO-08106, URCC 0701, URCC-O08106, NCT00924651
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-0976, NCT01202851
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: HT-ANAM-303, NCT01395914
|
|
6.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000727326, RTOG-1115, NCT01546987
|
|
7.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MIND, NCT01700959
|
|
8.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: A221101, N10C3, NCI-2012-02020, NCT01781468
|
|
9.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2009-0517, NCT01219673
|
|
10.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 18 to 64 Sponsor: NCI, Other Protocol IDs: 2010-0557, R01 026582-26, NCT01330446
|
|
11.
|
Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-02650, E1A10, CDR0000701362, U10CA021115, ECOG-E1A10, NCT01381692
|
|
12.
|
Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: R21CA164515, NCT01786187
|
|
13.
|
Phase: Phase II Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 06-08-010, NCT00646633
|
|
14.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Germanium, NCT00651417
|
|
15.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-341, NCT00766467
|
|
16.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 09-134, AVF 4571s; TBCRC 012, NCT00925652
|
|
17.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000656564, NCCTG-N07C4, N07C4, NCT00993928
|
|
18.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MMR-117597, NCT01034215
|
|
19.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000683312, ECOG-E2408, E2408, NCT01216683
|
|
20.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-0854, NCT01375114
|
|
21.
|
Phase: Phase II Type: Supportive care Status: Active Age: 6 to 17 Sponsor: NCI, Other Protocol IDs: CDR0000702733, SCUSF-0901, ACCL0922, NCT01381718
|
|
22.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 60 and over Sponsor: NCI, Other Protocol IDs: CDR0000707057, ECOG-E1411, E1411, NCT01415752
|
|
23.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-0389, NCT01410942
|
|
24.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: STU 042011-050, NCT01414738
|
|
25.
|
Phase: Phase II Type: Supportive care Status: Active Age: 8 to 21 Sponsor: Other Protocol IDs: 2011-14423, NCT01572168
|